Holen Sie sich die Stockscreener-App
29.90
0.10%
-0.03
Handel nachbörslich:
30.00
0.10
+0.33%
Schlusskurs vom Vortag:
$29.93
Offen:
$29.93
24-Stunden-Volumen:
250.89K
Relative Volume:
0.82
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.21B
Nettoeinkommen (Verlust:
$570.23M
KGV:
3.4538
EPS:
8.6571
Netto-Cashflow:
$-293.03M
1W Leistung:
+0.57%
1M Leistung:
+8.61%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$29.36
$30.02
1-Wochen-Bereich:
$28.50
$30.34
52-Wochen-Spanne:
$25.68
$32.41
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Firmenname
Lakefront Biotherapeutics Nv Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare LKFT vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
29.90 | 1.96B | 1.21B | 570.23M | -293.03M | 8.6571 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-23 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2026-08-21 | Eingeleitet | TD Cowen | Buy |
| 2026-07-10 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-10-22 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-08-05 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-02-14 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-11-20 | Herabstufung | Kepler | Hold → Reduce |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-03-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-08-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-23 | Hochstufung | Jefferies | Underperform → Hold |
| 2022-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-19 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-04-20 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Lakefront Biotherapeutics Nv Adr Aktie (LKFT) Neueste Nachrichten
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics - GlobeNewswire Inc.
Lakefront kondigt de verkoop aan van haar preklinische CAR-T-programma’s aan Armed Cell Therapeutics - GlobeNewswire Inc.
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated "Moderate Buy" by Sell-Side Analysts - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Shares Gap Up After Analyst Upgrade - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Upgraded to "Outperform" at Royal Bank Of Canada - MarketBeat
Press Releases about Lakefront BiotherapeuticsAmerican Depositary Shares (Nasdaq:LKFT) - FinancialContent
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig - Yahoo Finance
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
InMode Ltd. (INMD) Stock Price & News - Syfe
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
VALN Stock Price, Quote & News - Syfe
TD Cowen upgrades Lakefront Biotherapeutics stock rating to buy By Investing.com - Investing.com UK
TD Cowen upgrades Lakefront Biotherapeutics stock rating to buy - Investing.com
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA) - theglobeandmail.com
argenx SE (ARGX) Stock Price, News, Quote & History - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB) - The Globe and Mail
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
Lakefront Biotherapeutics director resigns for Sanofi role By Investing.com - Investing.com Nigeria
Lakefront Biotherapeutics director resigns for Sanofi role - Investing.com
Lakefront Biotherapeutics director resigns for Sanofi role By Investing.com - Investing.com Canada
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com Nigeria
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com South Africa
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com India
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com Canada
LKFTLakefront Biotherapeutics NV ADR Latest SEC Filings - Finviz
LKFTLakefront Biotherapeutics NV ADR Volatility & Greeks - Finviz
GXEA Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com South Africa
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com Nigeria
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com Canada
Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com
Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated - Bez Kabli
LKFT - Finviz
Lakefront Receives Transparency Notification from Bank of America - Yahoo Finance Australia
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com Australia
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com Nigeria
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com India
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com Canada
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
Lakefront Biotherapeutics American Depositary Shares (LKFT) Stock Price, News & Analysis - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026 - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (LKFT) Short Interest & Short Float | Updated Oct 2026 - MarketBeat
Lakefront Biotherapeutics American Depositary Shares (LKFT) Stock Forecast and Price Target 2026 - MarketBeat
LKFT: Lakefront BiotherapeuticsSponsored ADRComparison to Industry - Zacks Investment Research
Finanzdaten der Lakefront Biotherapeutics Nv Adr-Aktie (LKFT)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):